Annual Drug Patent Expirations for PROCYSBI
Procysbi is a drug marketed by Horizon Pharma Usa and is included in two NDAs. There are sixteen patents protecting this drug.
Drug patent litigation for PROCYSBI.
This drug has forty-five patent family members in thirty-three countries.
The generic ingredient in PROCYSBI is cysteamine bitartrate. Additional details are available on the cysteamine bitartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
